- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neovascular Age-related Macular Degeneration (NVAMD) in United Kingdom
Total 652 results
-
AsclepiX Therapeutics, Inc.TerminatedNeovascular Age-Related Macular Degeneration (nAMD)United States
-
Ocugenix CorporationNot yet recruitingNeovascular Age-related Macular Degeneration (nAMD)United States
-
AbbVieAbbVieEnrolling by invitationGene Therapy | AMD | nAMD | Wet AMD | Neovascular Age-Related Macular Degeneration (nAMD) | wAMDUnited States
-
SandozCompletedNeovascular Age-related Macular Degeneration (nAMD)United States
-
Aerie PharmaceuticalsAlcon ResearchRecruitingNeovascular Age-related Macular Degeneration (nAMD)United States
-
SandozCompletedNeovascular Age-related Macular Degeneration (nAMD)United States
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
EyeBiotech Ltd.RecruitingDiabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (NVAMD)United States, Argentina, Puerto Rico, United Kingdom
-
Kyowa Kirin, Inc.RecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States, Japan, Korea, Republic of, Australia
-
Exegenesis BioRecruitingNeovascular (Wet) Age-related Macular Degeneration (nAMD)United States
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Regeneron PharmaceuticalsActive, not recruitingDiabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)United States
-
Moorfields Eye Hospital NHS Foundation TrustCompletedNeovascular Age-related Macular DegenerationUnited Kingdom
-
AbbVieAbbVieRecruitingNeovascular Age-Related Macular Degeneration (nAMD)United States
-
Duke UniversityBausch & Lomb IncorporatedCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsCompletedNeovascular Age Related Macular DegenerationUnited States
-
Retina Macula InstituteCompletedNeovascular Age Related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedNeovascular Age Related Macular DegenerationUnited States
-
Iconic Therapeutics, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States
-
Johns Hopkins UniversityCompleted
-
Ocular Therapeutix, Inc.Duke University; FortreaRecruitingNeovascular Age-Related Macular DegenerationUnited States
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
Ocular Therapeutix, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States
-
Apellis Pharmaceuticals, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States, Australia
-
University of MiamiGenentech, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States
-
Hoffmann-La RocheCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsTerminatedNeovascular Age-Related Macular DegenerationUnited States, Japan
-
Sequenom, Inc.CompletedAge-related Macular Degeneration | Choroidal Neovascular Age-related Macular DegenerationUnited States
-
Retinal Consultants of ArizonaOphthotech CorporationCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Vitreous -Retina- Macula Consultants of New YorkUnknownNeovascular Age-Related Macular DegenerationUnited States
-
Lpath, Inc.UnknownNeovascular Age Related Macular DegenerationUnited States
-
Novartis PharmaceuticalsTerminatedNeovascular Age-related Macular DegenerationUnited Kingdom
-
David M. Brown, M.D.Genentech, Inc.TerminatedMacular Degeneration | Age Related Macular Degeneration | Wet Age-Related Macular Degeneration | Choroidal Neovascular Membrane | Subfoveal Neovascular Age-Related Macular DegenerationUnited States
-
Graybug VisionCompletedNeovascular Age-Related Macular DegenerationUnited States
-
BayerRegeneron PharmaceuticalsTerminatedNeovascular (Wet) Age-related Macular DegenerationCanada, United Kingdom
-
Retinal Consultants of ArizonaGenentech, Inc.CompletedNeovascular Age Related Macular DegenerationUnited States
-
Notal Vision Inc.CompletedNeovascular Age-related Macular Degeneration | Intermediate Age Related Macular Degeneration (Disorder)United States
-
King's College Hospital NHS TrustKing's College LondonActive, not recruitingNeovascular (Wet) Age-related Macular Degeneration (AMD)United Kingdom
-
Notal Vision Inc.CompletedNeovascular Age-related Macular DegenerationUnited States
-
REGENXBIO Inc.CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationSpain, Korea, Republic of, Czechia, Japan, Singapore, United States, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Portugal, Bulgaria, Latvia, Canada, Hungary, Arge... and more
-
Notal Vision Inc.RecruitingNeovascular Age-related Macular DegenerationUnited States
-
Clearside Biomedical, Inc.CompletedNeovascular Age-related Macular DegenerationUnited States
-
Tennessee RetinaRegeneron PharmaceuticalsUnknownNeovascular Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsRecruitingNeovascular Age-related Macular DegenerationUnited Arab Emirates
-
AiViva BioPharma, Inc.CompletedNeovascular Age-related Macular DegenerationUnited States
-
Oregon Health and Science UniversityCompletedNeovascular Age-related Macular DegenerationUnited States
-
Duke UniversityBausch & Lomb IncorporatedWithdrawnNeovascular Age-related Macular DegenerationUnited States
-
Notal Vision Inc.CompletedNeovascular Age-related Macular DegenerationUnited States